Omnicef and Neupogen drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Omnicef (cefdinir) and Neupogen (filgrastim). Common drug interactions include throat irritation among females and attention deficit/hyperactivity disorder among males.

The phase IV clinical study analyzes what interactions people have when they take Omnicef and Neupogen. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Omnicef?

Omnicef has active ingredients of cefdinir. It is often used in sinusitis. eHealthMe is studying from 2,774 Omnicef users. Check the latest studies of Omnicef.

What is Neupogen?

Neupogen has active ingredients of filgrastim. It is often used in agranulocytosis. eHealthMe is studying from 23,898 Neupogen users. Check the latest studies of Neupogen.

On Jul, 09, 2026

14 people who take Omnicef and Neupogen together, and have interactions are studied.

What are the common drug interactions of Omnicef and Neupogen, by gender? *:

female:

Throat irritation
Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
Blast cells present
Blood culture positive
Bronchiolitis (inflammation of the membranes lining the bronchioles in lungs)
Chloroma (green-coloured tumour)
Contusion (a type of hematoma of tissue in which capillaries)
Cranial nerve paralysis (loss of function of cranial nerve)
Culture stool positive
Facial palsy (paralysis of face nerve)

male:

Attention deficit/hyperactivity disorder
B-cell lymphoma (blood cancer affecting b cells)
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
Eczema eyelids (patches of skin become rough and inflamed, with itching and bleeding blisters on eyelid)
Lung neoplasm (tumour of lung)
Pyrexia (fever)
Reflux oesophagitis (an oesophageal mucosal injury that occurs of gastric contents into the oesophagus)
Rhinitis allergic (inflammation of the nasal airways due to allergy)
Suicidal ideation
Anger

What are the common drug interactions of Omnicef and Neupogen, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Attention deficit/hyperactivity disorder
B-cell lymphoma (blood cancer affecting b cells)
Chronic sinusitis (long lasting inflammation of the paranasal sinuses)
Conjunctivitis (pink eye)
Cough
Depression
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
Eczema eyelids (patches of skin become rough and inflamed, with itching and bleeding blisters on eyelid)
Lung neoplasm (tumour of lung)
Pyrexia (fever)

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Cytomegalovirus viraemia (cytomegalo virus in blood stream)
Febrile neutropenia (fever with reduced white blood cells)
Klebsiella bacteraemia (klebsiella bacteria in blood after infection to lungs)
Metabolic encephalopathy (disorder or disease of the brain due to the body's disability to use energy)
Mucosal inflammation (infection of mucous membrane)
Toxic encephalopathy (a degenerative neurologic disorder caused by exposure to toxic substances)
Vaginal haemorrhage (vaginal bleeding)
Pneumonia
Thrombocytopenia (decrease of platelets in blood)

60+:

n/a

What are the existing conditions these people have? *

Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 8 people, 57.14%
Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it): 2 people, 14.29%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 2 people, 14.29%
Pneumonia: 1 person, 7.14%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 1 person, 7.14%
Multiple Myeloma (cancer of the plasma cells): 1 person, 7.14%
Hypokalemia (low potassium): 1 person, 7.14%
Fluid Overload (too much fluid in the blood): 1 person, 7.14%
Eczema Eyelids (patches of skin become rough and inflamed, with itching and bleeding blisters on eyelid): 1 person, 7.14%
Breast Cancer Female: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Omnicef and Neupogen?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously